Eli Lilly and Company operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other
companies in this sector in UNITED STATES :
sales of $34.61 billion
of which 34%
was Medical Devices),
Regeneron Pharmaceuticals Incorporated
of which 58%
was EYLEA), and
of which 71%
was Developed markets).
Eli Lilly and Company reported sales of $24.54 billion
December of 2020.
increase of 9.9%
versus 2019, when the company's sales were $22.32 billion.
Despite this increase, sales are still
below the level achieved in 2018, when Eli Lilly and Company
reported sales of $24.56 billion.